Get the Stockscreener App
2.35
8.56%
-0.22
Pre-market:
2.31
-0.04
-1.70%
Minerva Neurosciences Inc stock is traded at $2.35, with a volume of 132.43K.
It is down -8.56% in the last 24 hours and up +9.38% over the past month.
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
See More
Previous Close:
$2.57
Open:
$2.42
24h Volume:
132.43K
Relative Volume:
0.80
Market Cap:
$16.43M
Revenue:
-
Net Income/Loss:
$-33.65M
P/E Ratio:
-0.5281
EPS:
-4.45
Net Cash Flow:
$-20.83M
1W Performance:
+11.90%
1M Performance:
+9.38%
6M Performance:
+74.07%
1Y Performance:
-11.65%
1-Day Range:
$2.31
$2.6001
1-Week Range:
$2.08
$3.2899
52-Week Range:
$1.15
$3.2899
Minerva Neurosciences Inc Stock (NERV) Company Profile
Name
Minerva Neurosciences Inc
Sector
Industry
Phone
617-600-7373
Address
1601 TRAPELO ROAD, WALTHAM, MA
Compare NERV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
2.35 | 17.97M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-08-20 | Reiterated | H.C. Wainwright | Buy |
| May-14-20 | Initiated | BTIG Research | Buy |
| Oct-02-19 | Reiterated | Chardan Capital Markets | Buy |
| Sep-25-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-18-19 | Initiated | William Blair | Outperform |
| May-31-19 | Initiated | H.C. Wainwright | Buy |
| Sep-01-17 | Initiated | Citigroup | Buy |
| Mar-06-17 | Resumed | Jefferies | Buy |
| May-12-16 | Resumed | Jefferies | Buy |
View All
Minerva Neurosciences Inc Stock (NERV) Latest News
Chart based exit strategy for Minerva Neurosciences Inc.Trade Risk Report & Daily Price Action Insights - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.July 2025 Decliners & High Return Stock Watch Alerts - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.2025 Year in Review & Daily Momentum Trading Reports - newser.com
Reversal indicators forming on Minerva Neurosciences Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Can technical indicators confirm Minerva Neurosciences Inc.’s reversalJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Is Minerva Neurosciences Inc. a candidate for recovery playMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com
Key resistance and support levels for Minerva Neurosciences Inc.2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Parkinson Disease Pipeline Drugs 2025 Report: Emerging Drugs, Innovative Therapies, Clinical Trial Updates, and Top Companies - Barchart.com
Would You Accumulate or Wait on JTEKT India Limited (JTEKTINDIA)Earnings Per Share Trends & Free Explosive Trading Growth - earlytimes.in
Is Minerva Neurosciences Inc. stock dividend yield sustainableTrend Reversal & Risk Managed Trade Strategies - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
What analysts say about Minerva Neurosciences Inc 4MNA stockMarket Correction Analysis & Outperform the Market with Aggressive Picks - earlytimes.in
Chart based analysis of Minerva Neurosciences Inc. trendsSell Signal & High Win Rate Trade Tips - newser.com
Is it time to cut losses on Minerva Neurosciences Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
ProShares Trust ProShares UltraShort MSCI Japan Stock Analysis and ForecastStock Market Trends & Small Investment Growth Tips - earlytimes.in
What drives CopAur Minerals Inc RFC4 stock priceInsider Buying Signals & Low Risk Trading Plans - earlytimes.in
What analysts say about Shutterstock Inc stockRetail Trading Trends & Budget Friendly Growth - earlytimes.in
Does Minerva Neurosciences Inc. qualify in momentum factor screeningMarket Trend Report & Reliable Entry Point Alerts - newser.com
What drives Minerva Neurosciences Inc stock priceSell Signals and Alerts & Tap Into the Fastest-Growing Companies - earlytimes.in
Is Farmer Bros. Co. stock a buy on dipsTrade Entry Report & Verified Entry Point Signals - newser.com
Minerva Neurosciences Inc Stock Analysis and ForecastPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in
What market sentiment indicators show for Algernon Pharmaceuticals Inc. (AGW0) stock2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Best data tools to analyze OSR Holdings Inc. stockJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com
How RSPH stock behaves in tightening cyclesWeekly Gains Report & AI Powered Market Trend Analysis - newser.com
Is Dimensional ETF Trust Dimensional World stock a buy during volatile marketsPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
What hedge fund moves indicate for Schroder BSC Social Impact Trust plc (783) stockEarnings Trend Report & Verified Technical Trade Signals - newser.com
Why Carlton Precious Inc. (IVH) stock is trending on social media2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
How to use Fibonacci retracement on SITCJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Sentiment Recap: Is Minerva Neurosciences Inc. stock suitable for long term investingMarket Risk Analysis & Verified Stock Trade Ideas - خودرو بانک
Minerva Neurosciences Inc. stock trend forecast2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Aug Patterns: Is Minerva Neurosciences Inc. stock showing strong momentumJuly 2025 Earnings & Low Risk Profit Maximizing Plans - خودرو بانک
How to manage a losing position in RDCMRisk Management & Daily Profit Maximizing Tips - newser.com
Income Plays: Is Minerva Neurosciences Inc. in a consolidation phaseJuly 2025 Movers & Safe Entry Momentum Stock Tips - خودرو بانک
Minerva Neurosciences Inc Stock (NERV) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):